Search - tctmd.com

Displaying 601 - 620 of 674

Sort: Relevancy | Date

News Daily News

Low Mortality, Stroke With Transfemoral Implant of Sapien 3

December 04, 2014

News Daily News

More Prosthesis-Patient Mismatch with Surgery vs TAVR, Linked to Worse Outcomes

October 03, 2014

Presentation TCT 2014

TAVR Combined Procedures - Coronary Stenting and LAA Closure

Presenter: Fabian Nietlispach

September 16, 2014

Presentation TCT 2014

TAVR Gulf Experience and a Difficult TAVR Case

Presenter: George D. Dangas, Ziyad M. Hijazi, Roxana Mehran, Abdullah Shehab, Mohammed Balghith

September 16, 2014

Presentation TCT 2014

Case #2: A Coronary Dissection Extending to the Ascending Aorta

Presenter: Thierry Corcos, Habib Gamra, Christopher J J. White, Dhaker LAHIDHEB

September 15, 2014

Presentation TCT 2014

Risks, Consequences, and Treatment of Coronary Occlusion During TAVR

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib, Henrique B. Ribeiro

September 14, 2014

Presentation TCT 2014

Coronary Artery Disease and TAVR: Who, When, and How to Revascularize?

Presenter: Sarah Clarke, Marian C. Hawkey, Thomas H. Maloney, Jeffrey J. Popma

September 14, 2014

Presentation TCT 2014

Case #9. How to Handle Threatened Coronary Arteries with Sapien

Presenter: Gregory P. Fontana, Jean-Claude Laborde, Raj Makkar

September 13, 2014

Presentation TCT 2014

Case #8. How to Handle Threatened Coronary Arteries with CoreValve

Presenter: Gregory P. Fontana, Jean-Claude Laborde, Azeem Latib

September 13, 2014

News Conference News TCT 2014

Disparity Seen Between Aortic Valve-in-Valve Implantation for Stented, Stentless Devices

September 13, 2014

News Daily News

不完全的血运重建与患CAD的TAVR患者的较差结果有联系

September 11, 2014

News Daily News

La Revascularización Incompleta se asocia a Peores Resultados en Pacientes TAVR con EAC

September 11, 2014

News Daily News

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

September 11, 2014

News Conference News ESC 2014

GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular

Caitlin E. Cox

September 02, 2014

News Daily News

VIVID Registry: Benefit of Valve-in-Valve TAVR Depends on Size, Status of Failed Surgical Bioprosthesis

July 10, 2014

Presentation TVT 2014

Coronary Occlusion After TAVR: Review from a Multicenter Experience

Presenter: Jean-Michel Paradis

June 07, 2014

Presentation TVT 2014

Ad Hoc TAVI, Coronary Stenting, and LAA Closure

Presenter: Fabian Nietlispach

June 07, 2014

Presentation TVT 2014

Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials)

Presenter: Alexandra J. Lansky

June 06, 2014

Presentation TVT 2014

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Presenter: Susheel Kodali

June 06, 2014

Presentation TVT 2014

Histo-Pathology Debris Analysis and Status of the MISTRAL C Randomized Trial

Presenter: Nicolas M. van Mieghem

June 06, 2014

Advertisement

Low Mortality, Stroke With Transfemoral Implant of Sapien 3

More Prosthesis-Patient Mismatch with Surgery vs TAVR, Linked to Worse Outcomes

TAVR Combined Procedures - Coronary Stenting and LAA Closure

TAVR Gulf Experience and a Difficult TAVR Case

Case #2: A Coronary Dissection Extending to the Ascending Aorta

Risks, Consequences, and Treatment of Coronary Occlusion During TAVR

Coronary Artery Disease and TAVR: Who, When, and How to Revascularize?

Case #9. How to Handle Threatened Coronary Arteries with Sapien

Case #8. How to Handle Threatened Coronary Arteries with CoreValve

Disparity Seen Between Aortic Valve-in-Valve Implantation for Stented, Stentless Devices

不完全的血运重建与患CAD的TAVR患者的较差结果有联系

La Revascularización Incompleta se asocia a Peores Resultados en Pacientes TAVR con EAC

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular

VIVID Registry: Benefit of Valve-in-Valve TAVR Depends on Size, Status of Failed Surgical Bioprosthesis

Coronary Occlusion After TAVR: Review from a Multicenter Experience

Ad Hoc TAVI, Coronary Stenting, and LAA Closure

Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials)

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Histo-Pathology Debris Analysis and Status of the MISTRAL C Randomized Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content